TY - JOUR
T1 - Iodine-131-meta-iodobenzylguanidine therapy for patients with high-risk neuroblastoma
AU - Kraal, Kathelijne C.J.M.
AU - van Dalen, Elvira C.
AU - Tytgat, Godelieve A.M.
AU - Van Eck-Smit, Berthe L.
AU - Caron, Huib N.
N1 - Publisher Copyright:
© 2013 The Cochrane Collaboration.
PY - 2013/2/28
Y1 - 2013/2/28
N2 - This is the protocol for a review and there is no abstract. The objectives are as follows: To assess the efficacy of 131I-MIBG therapy in patients with newly diagnosed, relapsed and/or refractory high-risk NBL.
AB - This is the protocol for a review and there is no abstract. The objectives are as follows: To assess the efficacy of 131I-MIBG therapy in patients with newly diagnosed, relapsed and/or refractory high-risk NBL.
UR - http://www.scopus.com/inward/record.url?scp=85048480307&partnerID=8YFLogxK
U2 - 10.1002/14651858.CD010349
DO - 10.1002/14651858.CD010349
M3 - Article
AN - SCOPUS:85048480307
SN - 1469-493X
VL - 2013
JO - Cochrane Database of Systematic Reviews
JF - Cochrane Database of Systematic Reviews
IS - 2
M1 - CD010349
ER -